These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9714293)

  • 1. Effects of the mitogen-activated protein (MAP) kinase kinase inhibitor 2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one (PD98059) on human platelet activation.
    McNicol A; Philpott CL; Shibou TS; Israels SJ
    Biochem Pharmacol; 1998 Jun; 55(11):1759-67. PubMed ID: 9714293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets.
    Börsch-Haubold AG; Kramer RM; Watson SP
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):207-12. PubMed ID: 8761473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
    Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
    Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha.
    Minuz P; Gaino S; Zuliani V; Tommasoli RM; Benati D; Ortolani R; Zancanaro C; Berton G; Santonastaso CL
    Thromb Haemost; 2002 May; 87(5):888-98. PubMed ID: 12038794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of collagen-induced platelet activation by arachidonyl trifluoromethyl ketone.
    McNicol A; Nickolaychuk BR
    Biochem Pharmacol; 1995 Nov; 50(11):1795-802. PubMed ID: 8615857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets.
    McNicol A; Jackson EC
    Biochem Pharmacol; 2003 Apr; 65(8):1243-50. PubMed ID: 12694865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotides inhibit MAP kinase activity in low-dose collagen-stimulated platelets.
    Jackson EC; McNicol A
    Thromb Res; 2010 Feb; 125(2):147-51. PubMed ID: 19595442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine von Willebrand factor and thrombin induce the activation of c-Jun amino-terminal kinase (JNK/SAPK) whereas only thrombin induces activation of extracellular signal-related kinase 2 (ERK2) in human platelets.
    Song S; Freedman J; Mody M; Lazarus AH
    Br J Haematol; 2000 Jun; 109(4):851-6. PubMed ID: 10929041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
    Nakashima S; Koike T; Nozawa Y
    Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of an inhibitor of diglyceride lipase on collagen-induced platelet activation.
    Jackson EC; Ortar G; McNicol A
    J Pharmacol Exp Ther; 2013 Dec; 347(3):582-8. PubMed ID: 24042163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.
    Iida Y; Doi T; Tokuda H; Matsushima-Nishiwaki R; Tsujimoto M; Kuroyanagi G; Yamamoto N; Enomoto Y; Tanabe K; Otsuka T; Iwama T; Ogura S; Kozawa O; Iida H
    Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():73-81. PubMed ID: 25500336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways.
    Börsch-Haubold AG; Ghomashchi F; Pasquet S; Goedert M; Cohen P; Gelb MH; Watson SP
    Eur J Biochem; 1999 Oct; 265(1):195-203. PubMed ID: 10491174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anisomycin does not activate p38MAPK in human platelets.
    Pampolina C; McNicol A
    Thromb Res; 1999 Oct; 96(1):27-35. PubMed ID: 10554082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.
    Xiao L; Pimental DR; Amin JK; Singh K; Sawyer DB; Colucci WS
    J Mol Cell Cardiol; 2001 Apr; 33(4):779-87. PubMed ID: 11273730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
    Kuliopulos A; Mohanlal R; Covic L
    Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for p38 MAP kinase in platelet activation by von Willebrand factor.
    Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M
    Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Thrombin inhibits signal transducers and activators of transcription 3 signaling by interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor in CCL39 cells.
    Bhat GJ; Hunt RA; Baker KM
    Arch Biochem Biophys; 1998 Feb; 350(2):307-14. PubMed ID: 9473306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.